Cargando…
Ivabradine in Congestive Heart Failure: Patient Selection and Perspectives
Heart failure (HF) is the fourth-most frequent cause of death and remains a challenge for public health. Therapy goals for HF with reduced ejection fraction (HFrEF) are the improvement in the quality of life, prolonged survival, a reduction of signs and symptoms, and the prevention of hospitalizatio...
Autores principales: | Sattar, Yasar, Neisani Samani, Elham, Zafrullah, FNU, Latchana, Sharaad, Patel, Nirav B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561528/ https://www.ncbi.nlm.nih.gov/pubmed/31205834 http://dx.doi.org/10.7759/cureus.4448 |
Ejemplares similares
-
Diagnosis and Management of a Cardiac Amyloidosis Case Mimicking Hypertrophic Cardiomyopathy
por: Sattar, Yasar, et al.
Publicado: (2018) -
Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
por: Nadeem, Muhammad, et al.
Publicado: (2020) -
Suspecting Cardiac Amyloidosis in Congestive Heart Failure
por: Alatassi, Emad U, et al.
Publicado: (2020) -
Acute Heart Failure in an Almost-Centenarian Patient With Symptomatic Severe Aortic Stenosis Treated With Ivabradine
por: Sato, Hiroki, et al.
Publicado: (2022) -
A Study of Vitamin D and Its Correlation With Severity and Complication of Congestive Heart Failure: A Systematic Review
por: Hazique, Mohammad, et al.
Publicado: (2022)